Brian Reed

Title: Brian Reed: Innovator in Kappa Opioid Receptor Ligands

Introduction

Brian Reed is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target kappa opioid receptors. His work aims to address critical health issues such as addiction, pain, and inflammation.

Latest Patents

Brian Reed holds a patent for "Pyrano[3,4-b]pyrazine kappa opioid receptor ligands for treating addiction, pruritus, pain, and inflammation." This patent, which includes the compound 1-Phenylacetyl-8-aminohexahydro-2H-pyrano[3,4-b]pyrazines, is designed to be effective in treating drug dependency and related conditions. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Brian Reed is affiliated with The Rockefeller University, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving therapeutic options for patients suffering from various ailments.

Collaborations

Throughout his career, Brian has collaborated with esteemed colleagues, including Mary Jeanne Kreek and Amy Ripka. These partnerships have enhanced the scope and impact of his research, contributing to the advancement of knowledge in the field.

Conclusion

Brian Reed's innovative work in developing kappa opioid receptor ligands represents a significant advancement in the treatment of addiction and related health issues. His contributions continue to influence the field of pharmacology and improve patient outcomes.